Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964379 · ClinicalTrials.gov registry record · Phase 3
Intraperitoneal Versus Extraperitoneal Colostomy
A Phase 3 study of Colostomy, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 81
- Enrollment target
- 1
- Study location
NCT00964379: Completed Phase 3 study of Colostomy, sponsored by Mayo Clinic.
NCT00964379 is a Phase 3 study of Colostomy that has completed, run by Mayo Clinic. The registered enrollment target is 81 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00964379, a Phase 3 study of Colostomy, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective randomized trial of intraperitoneal versus extraperitoneal techniques for construction of terminal iliac fossa colostomies.
Conditions Studied
Interventions
- PROCEDURE intraperitoneal or extraperitoneal colostomy
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 1988-01 |
| Est. Completion | 2013-06 |
| Phase | Phase 3 |
What the finished NCT00964379 record still lists
NCT00964379 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Colostomy appearing as the primary indexed condition, and to 1 intervention - of which intraperitoneal or extraperitoneal colostomy is the first listed.
NCT00964379 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00964379 about?
NCT00964379 is a clinical study titled "Intraperitoneal Versus Extraperitoneal Colostomy". This is a prospective randomized trial of intraperitoneal versus extraperitoneal techniques for construction of terminal iliac fossa colostomies.
What is the current status of trial NCT00964379?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 81 participants. The study started on 1988-01. Estimated completion is 2013-06.
What conditions does trial NCT00964379 study?
This clinical trial studies the following conditions: Colostomy.
What interventions are being tested in trial NCT00964379?
The interventions under investigation include: intraperitoneal or extraperitoneal colostomy (PROCEDURE).
Who is sponsoring clinical trial NCT00964379?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00964379 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colostomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00964379's enrollment target sits among peer trials
81 1752nd of 2000 higher than 246 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia